| |
Newsroom /
Medical
/
Medical
/
Drug Device Combination Market to 2016
Drug Device Combination Market to 2016
The report provides market landscape, competitive landscape and market trends information on five drug device combination market categories
London,
London,
United Kingdom
(prbd.net)
28/01/2011
The Drug/Device CP market is valued at $8.4 billion in 2009 and it is expected to grow at a CAGR of 12.6% during the period 2007-2016. The US market for Drug/Device CP is the largest geographical market comprising nearly 47.6 % of the global markets. The drug-eluting stent market is the largest market within the Drug/Device CP market, making up nearly 57.1 % of the total market in 2009. However, the drug-eluting bead market is the fastest micro-market among the segments within the scope of this study with a CAGR of 59.1% during the period 2007-2016.
For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Drug-Device-Combination-Market-to-2016-%C2%A0Technological-Convergence-to-be-the-New-Business-Model-for-Growth-and-Profitability&ReportType=Industry_Report&coreindustry=ALL&Title=Medical_Devices
Improved clinical outcomes of Drug/Device combination products as compared to its individual components, namely the medical device or the drug, has resulted in high growth of this market, with the CAGR estimated to be in double digit figures. Therapeutic efficiency of the drug in a CP is enhanced as a result of the controlled drug delivery locally, thus, also avoiding systemic toxicity. The anti-infective properties of the antimicrobial or antibiotic coatings on catheters and bone cements respectively permit the device to perform its functions for a longer period of time. This improved efficiency of the CP also, thus, improves the functional life of the implanted or inserted device. These benefits have resulted in greater user acceptance worldwide, and hence, the global revenues from this macro-market within the healthcare industry are poised for sharp growth in the next seven years corresponding to the period of this study.
GBI Research’s report, “Drug Device Combination Market to 2016 – Technological Convergence to be the New Business Model for Growth and Profitability” provides key data, information and analysis on the drug device combination market. The report provides market landscape, competitive landscape and market trends information on five drug device combination market categories – Drug-Eluting Stents, Antimicrobial Catheters, Antibiotic-Loaded Bone Cements, Drug Eluting Beads (DEB) and Photodynamic Therapy The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and a detailed analysis of the pipeline products. The report also reviews details about important merger and acquisition deals that have taken place in the drug device combination market during the past three years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Drug-Device-Combination-Market-to-2016-%C2%A0Technological-Convergence-to-be-the-New-Business-Model-for-Growth-and-Profitability&ReportType=Industry_Report&coreindustry=ALL&Title=Medical_Devices
Visit our report store: http://www.gbiresearch.com
For more details contact:
pressreleases@gbiresearch.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782
About
GBI Research is a global market intelligence services company providing information research and analysis products and services.
|